Developmental and transplacental genotoxicology: fluconazole
Aleksandra Fucic1, Darko Markovic, Zdenko Herceg
1Institute for Medical Research and Occupational Health, Ksaverska 2, 10000 Zagreb, Croatia. afucic@imi.hr
Mutation Research
|September 16, 2008
Summary
Young organisms are more sensitive to genotoxic agents than adults. This study shows fluconazole causes genome damage in young mice and pups, highlighting age-related chemosensitivity and risks during development.
Area of Science:
- Environmental Health
- Toxicology
- Developmental Biology
Background:
- Increasing childhood cancer incidence despite efforts to limit genotoxic exposure.
- Genotoxic agents can cause multi-step cancer development starting from prenatal and childhood exposure.
- Developing organisms (fetus, child) must adapt to xenobiotic environments, with potential long-lasting or transgenerational effects.
Purpose of the Study:
- To evaluate age-related differences in genotoxicity and transplacental potency of fluconazole (FC).
- To investigate the impact of developmental stage on sensitivity to radiochemical agents.
Main Methods:
- In vivo micronucleus (MN) assay was used to assess genome damage.
- Experiments were conducted on adult mice, young mice, and transplacentally exposed newborn pups.
- Fluconazole (FC) was administered to evaluate its genotoxic effects across different age groups.
Main Results:
- Fluconazole (FC) did not cause detectable genome damage in adult mice compared to baseline.
- A significant increase in micronucleus (MN) frequency was observed in young mice and newborn pups exposed to FC.
- Results indicate age-related differences in sensitivity to genotoxic agents.
Conclusions:
- The study demonstrates age-related chemosensitivity, with younger organisms exhibiting higher susceptibility to genotoxic agents like fluconazole.
- Disturbances in prenatal development and childhood maturation due to genotoxic exposures necessitate a systems biology approach for cancer prevention.
- Further research is needed to understand the influence of factors like sex hormones on radiochemical sensitivity, especially during puberty.
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
01:28Development of the Oral Microbiota
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...